$10M Increase Company’s Share Repurchase Program

MiMedx Board of Directors Authorizes $10 Million Increase to the Company’s Share Repurchase Program

MARIETTA, Ga., Oct. 9, 2017 /PRNewswire/ — MiMedx Group, Inc. (NASDAQ: MDXG), the leading biopharmaceutical company developing and marketing regenerative and therapeutic biologics…